TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16433867

Group type: EXPERIMENTAL
Intervention: Ivabradine (30 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 9
Study: 15569238

Group type: COMPARATOR
Intervention: HPA‐15 gene frequencies in Caucasians (0.53/0.47), African Brazilians (0.57/0.43), Orientals (0.57/0.43), and Brazilian blood donors (0.52/0.48)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: HPA‐15 gene frequencies in Xikrin Indians (0.78/0.22)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: HPA‐15 genotype frequencies in Gaviões Indians
Number of subjects: 276
Study: 11061579

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.8 mg with itraconazole 200 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg with itraconazole 200 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg with itraconazole 200 mg
Number of subjects: 18
Study: 9315425

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 8482184

Group type: EXPERIMENTAL
Intervention: Misoprostol (800 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Misoprostol (400 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3514488

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg nocte
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d.
Number of subjects: 45
Study: 30468408

Group type: EXPERIMENTAL
Intervention: Media Aware program
Number of subjects: 880

Group type: COMPARATOR
Intervention: Health promotion control
Number of subjects: 880
Study: 27595414

Group type: EXPERIMENTAL
Intervention: Nurse-led management model (n=36)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Doctor-led management model (n=37)
Number of subjects: 73
Study: 24050682

Group type: EXPERIMENTAL
Intervention: Body armour (loaded)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Distracted drop landing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Unloaded (control)
Number of subjects: 52
Study: 22875553

Group type: EXPERIMENTAL
Intervention: Intensive Program (IP)
Number of subjects: 1416

Group type: EXPERIMENTAL
Intervention: Reduced Program (RP)
Number of subjects: 1416

Group type: EXPERIMENTAL
Intervention: Vitamin A intake from OSP
Number of subjects: 1416
Study: 20175283

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine (Group L, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.25% bupivacaine (Group B, n = 30)
Number of subjects: 60
Study: 17971487

Group type: EXPERIMENTAL
Intervention: R-DHAP (rituximab + DHAP chemotherapy)
Number of subjects: 225

Group type: COMPARATOR
Intervention: DHAP (chemotherapy without rituximab)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: R-DHAP
Number of subjects: 225

Group type: COMPARATOR
Intervention: DHAP
Number of subjects: 225
Study: 15948814

Group type: EXPERIMENTAL
Intervention: Immediate-release omeprazole (bedtime dosing)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pantoprazole (once daily predinner dosing)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pantoprazole (twice daily prebreakfast and bedtime dosing)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Immediate-release omeprazole (twice daily dosing 20 and 40 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Immediate-release omeprazole (40 mg bedtime dosing)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pantoprazole (twice daily dosing 40 mg)
Number of subjects: 36
Study: 12756503

Group type: EXPERIMENTAL
Intervention: Technetium-99m tetrofosmin (TF) washout
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: TF washout
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: TF uptake
Number of subjects: 31
Study: 10368917

Group type: EXPERIMENTAL
Intervention: Intervention program designed to enhance mother-infant interaction
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group intervention emphasizing basic caregiving skills
Number of subjects: 36
Study: 8678062

Group type: EXPERIMENTAL
Intervention: Anticoagulant citrate dextrose-A (ACD) (0.113 mol/L citrate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hypertonic tri-sodium citrate (TSC) (1.6 mol/L citrate)
Number of subjects: 8
Study: 1762669

Group type: EXPERIMENTAL
Intervention: Priming effects in amnesic patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Priming effects in young subjects
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Priming effects in age-matched control subjects
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Recognition of words in amnesic patients
Number of subjects: 9
Study: 6401229

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (TNG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral isosorbide dinitrate (ISDN) and topical 2% nitroglycerin ointment (NO)
Number of subjects: 40
Study: 31624854

Group type: EXPERIMENTAL
Intervention: Short-term dialysis catheters (DC)
Number of subjects: 3029

Group type: COMPARATOR
Intervention: Central venous catheters (CVC)
Number of subjects: 3029
Study: 28234775

Group type: EXPERIMENTAL
Intervention: Simple randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Block randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Techniques to account for confounding variables
Number of subjects: 0
Study: 26830377

Group type: EXPERIMENTAL
Intervention: Proton radiotherapy (craniospinal irradiation of 18-36 GyRBE delivered at 1.8 GyRBE per fraction)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Proton radiotherapy
Number of subjects: 59
Study: 24174275

Group type: EXPERIMENTAL
Intervention: landiolol hydrochloride 0.125 mg/kg
Number of subjects: 258

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 258
Study: 22770832

Group type: EXPERIMENTAL
Intervention: Readiness to change behavior for 2 daily servings of milk
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Readiness to change behavior for 4 daily servings of milk
Number of subjects: 75
Study: 19582636

Group type: EXPERIMENTAL
Intervention: BMI chart prompt in electronic medical record
Number of subjects: 846

Group type: COMPARATOR
Intervention: No BMI chart prompt in electronic medical record
Number of subjects: 846

Group type: EXPERIMENTAL
Intervention: Obesity comorbidities (specifically obstructive sleep apnea)
Number of subjects: 846
Study: 17505300

Group type: EXPERIMENTAL
Intervention: Oxygen delivery (DO2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Transcutaneous pressure of oxygen (PtcO2)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: PtcO2 goal at 24 h after resuscitation (T24)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Oxygen challenge test (OCT)
Number of subjects: 69
Study: 16243988

Group type: EXPERIMENTAL
Intervention: Granisetron 0.1 mg plus Dexamethasone 8 mg (G+D)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Ondansetron 4 mg plus Dexamethasone 8 mg (O+D)
Number of subjects: 176
Study: 12195324

Group type: EXPERIMENTAL
Intervention: Wireless capsule endoscopy (CE)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Push enteroscopy (PE)
Number of subjects: 65
Study: 9842758

Group type: EXPERIMENTAL
Intervention: High-visual complexity pictures
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low-visual complexity pictures
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 6
Study: 7988580

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2648657

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 301

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 301
Study: 29553033

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (12.9 mmol nitrate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (0.5 mmol nitrate)
Number of subjects: 20
Study: 29084686

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 120

Group type: COMPARATOR
Intervention: Amlodipine besilate (Control)
Number of subjects: 120
Study: 25979249

Group type: EXPERIMENTAL
Intervention: CadC with intact linker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CadC with truncated linker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CadC dimerization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CadC variant lacking most of the linker
Number of subjects: 0
Study: 23654110

Group type: EXPERIMENTAL
Intervention: 3% L-arabinose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5% L-arabinose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10% L-arabinose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: L-arabinose (daily for six months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 21713377

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine administration
Number of subjects: 192
Study: 18718892

Group type: COMPARATOR
Intervention: FOLFIRI (irinotecan 180 mg/m² on day 1 + 5-fluorouracil 400 mg/m² bolus and 600 mg/m² 22-h infusion + leucovorin 200 mg/m² on days 1-2, every 2 weeks)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: FUIRI (irinotecan 80 mg/m² + 5-fluorouracil 2,250 mg/m² 48-h infusion, weekly)
Number of subjects: 346

Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: FUIRI
Number of subjects: 346
Study: 17008196

Group type: EXPERIMENTAL
Intervention: Motivational interviewing targeted to smoking behaviors exclusively (smoking only)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Motivational interviewing targeted to smoking and other addictions or life events (smoking plus)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nicotine patches (21 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nicotine lozenges (4 mg)
Number of subjects: 46
Study: 15273014

Group type: EXPERIMENTAL
Intervention: Manipulation of gender fairness of a math test
Number of subjects: 0
Study: 11214850

Group type: EXPERIMENTAL
Intervention: Problem-based Alcohol Early Intervention Education Package (AEIEP)
Number of subjects: 212
Study: 9714485

Group type: EXPERIMENTAL
Intervention: Surgical treatment of aortic coarctation
Number of subjects: 44
Study: 7978588

Group type: EXPERIMENTAL
Intervention: Nasal midazolam (0.25 mg/kg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 58
Study: 2657523

Group type: EXPERIMENTAL
Intervention: Topical benzocaine 20% gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 40
Study: 30797989

Group type: EXPERIMENTAL
Intervention: Motivational Imagery condition (N = 24)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Activity Reminder control condition (N = 24)
Number of subjects: 72

Group type: COMPARATOR
Intervention: No-Reminder control condition (N = 24)
Number of subjects: 72
Study: 25751123

Group type: EXPERIMENTAL
Intervention: IPV-focused group intervention
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Common factors community-based group intervention
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Trauma-specific factors in child sessions
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Nonspecific treatment factors in child and parent sessions
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Nonspecific treatment factors in parent intervention
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Trauma-specific factors in intervention
Number of subjects: 134
Study: 26089386

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 810

Group type: COMPARATOR
Intervention: Insulin Glargine
Number of subjects: 810
Study: 22903789

Group type: EXPERIMENTAL
Intervention: Tubeless mPCNL (ureteric catheter but no drainage tubes)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional mPCNL (ureteric Double‐J stents and nephrostomy drainage tubes)
Number of subjects: 32
Study: 21889137

Group type: EXPERIMENTAL
Intervention: Dual observation by colonoscopist and endoscopy nurse
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Dual observation by colonoscopist and endoscopy nurse with fellows (<500 colonoscopies)
Number of subjects: 844

Group type: COMPARATOR
Intervention: Single observation by colonoscopist alone
Number of subjects: 844
Study: 19217168

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Specialized psychotherapy for chronic depression
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and psychotherapy
Number of subjects: 681

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 681
Study: 17117692

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.4 mgr/0.2 ml) applied in 150 patients for 5 minutes during surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (50 patients without mitomycin C)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 200
Study: 15001969

Group type: EXPERIMENTAL
Intervention: 200 mL normal-strength orange juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 11286609

Group type: EXPERIMENTAL
Intervention: Baclofen (40 mg maximum daily dose, given three times per day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Clonidine (0.8 mg maximum daily dose, given three times per day)
Number of subjects: 62
Study: 9401844

Group type: EXPERIMENTAL
Intervention: Rehydrated Hemoccult II tests (HII group)
Number of subjects: 6367

Group type: COMPARATOR
Intervention: Flexible videosigmoidoscopy (FS group)
Number of subjects: 6367

Group type: COMPARATOR
Intervention: Flexible sigmoidoscopy subgroup with HII tests
Number of subjects: 6367

Group type: COMPARATOR
Intervention: Flexible sigmoidoscopy
Number of subjects: 6367

Group type: EXPERIMENTAL
Intervention: Rehydrated HII tests
Number of subjects: 6367
Study: 8430057

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK (95 mg metoprolol succinate)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: metoprolol OROS (95 mg metoprolol fumarate)
Number of subjects: 18

Group type: COMPARATOR
Intervention: immediate-release tablet (100 mg metoprolol tartrate)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK and metoprolol OROS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK
Number of subjects: 18
Study: 31545155

Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100 Hz stimulation group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 28614194

Group type: EXPERIMENTAL
Intervention: Classroom physical activity lessons (two 10-min sessions per day, 5 days a week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no classroom PA lessons)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classroom physical activity lessons
Number of subjects: 0
Study: 26034150

Group type: EXPERIMENTAL
Intervention: Pregabalin (optimized to 300 or 450 mg/day)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 23824561

Group type: EXPERIMENTAL
Intervention: Psychosocial screening instrument
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Early referral for psychosocial treatment
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group (no psychosocial screening)
Number of subjects: 568
Study: 21798429

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 5 mg/kg/day
Number of subjects: 111

Group type: COMPARATOR
Intervention: Heparin/warfarin (started within 24 h of heparin lead-in; target INR: 2.0 to 3.0)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both ASA and heparin/warfarin
Number of subjects: 111
Study: 19205162

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for tinnitus, 8 weeks duration
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 65
Study: 16785057

Group type: EXPERIMENTAL
Intervention: Fluoroscopically assisted semiflexed anteroposterior (AP) radiographs
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-fluoroscopic fixed-flexion (FF) radiographs
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metatarsophalangeal (MTP) radiographs
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paired radiographs with parallel or near-parallel alignment
Number of subjects: 80
Study: 14616414

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily with voriconazole 200 mg twice daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily with voriconazole 200 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo with voriconazole 200 mg twice daily
Number of subjects: 12
Study: 10800240

Group type: EXPERIMENTAL
Intervention: Inhalation sedation
Number of subjects: 101

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 101
Study: 8833544

Group type: EXPERIMENTAL
Intervention: Pirenzepine (10 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Biperiden lactate (4 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 1596550

Group type: EXPERIMENTAL
Intervention: Mangan‐DPDP (5 or 10 mumol/kg)
Number of subjects: 19
Study: 3883170

Group type: EXPERIMENTAL
Intervention: Potassium chloride, 60 mmol per day for six weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo tablets for six weeks
Number of subjects: 16
Study: 31305464

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (GLP-1RA) treatment for 6 months
Number of subjects: 164

Group type: COMPARATOR
Intervention: Not applicable (control group of healthy individuals)
Number of subjects: 164
Study: 29361042

Group type: EXPERIMENTAL
Intervention: Acetyl-L-Carnitine (ALC) 1000 mg three times a day for 24 weeks
Number of subjects: 409

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study: 26304771

Group type: EXPERIMENTAL
Intervention: ACT‐SOC
Number of subjects: 101

Group type: COMPARATOR
Intervention: MS
Number of subjects: 101
Study: 24885489

Group type: EXPERIMENTAL
Intervention: GPS location services
Number of subjects: 12
Study: 22801564

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (n=19)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Low-calorie diet plus fenofibrate (n=18)
Number of subjects: 37
Study: 20630162

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment (3 x 24-hour dietary recalls)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment for 2-3 year olds
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Dietary intake assessment for 4-5 year olds
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Added sugar intake assessment
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Sweetened beverage intake comparison between overweight and normal weight children
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Television viewing time assessment
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Moderate or vigorous activity assessment
Number of subjects: 135
Study: 17392729

Group type: EXPERIMENTAL
Intervention: Cranberry juice (200 ml t.i.d. for 10 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 10
Study: 16334158

Group type: EXPERIMENTAL
Intervention: 111In-HMFG1-F(ab')2 with lysine co-infusion
Number of subjects: 23

Group type: COMPARATOR
Intervention: 111In-HMFG1-F(ab')2 without lysine co-infusion
Number of subjects: 23
Study: 12468959

Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg/4 h intravenously for 7 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt
Number of subjects: 16
Study: 9579004

Group type: EXPERIMENTAL
Intervention: Brief educational intervention to increase fruit and vegetable consumption
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (usual service without intervention)
Number of subjects: 276
Study: 7806203

Group type: EXPERIMENTAL
Intervention: Phenytoin (DPH)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Healthy age-matched male controls
Number of subjects: 68
Study: 2496484

Group type: EXPERIMENTAL
Intervention: Moss nasoduodenal tube placement with esophagogastric decompression and immediate enteral feedings (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No nasoduodenal tube placement (Group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 1202192

Group type: EXPERIMENTAL
Intervention: Increase heart-rate group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Decrease heart-rate group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Initial session
Number of subjects: 32
Study: 30859221

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 27884802

Group type: EXPERIMENTAL
Intervention: Flexible Policy
Number of subjects: 4363

Group type: COMPARATOR
Intervention: Standard Policy
Number of subjects: 4363
Study: 25530502

Group type: EXPERIMENTAL
Intervention: Neonatal-bereavement-support DVD
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard bereavement care (controls)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: DVD nonviewers
Number of subjects: 18
Study: 24171982

Group type: EXPERIMENTAL
Intervention: One-visit endodontic treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Two-visit endodontic treatment
Number of subjects: 100
Study: 22379833

Group type: EXPERIMENTAL
Intervention: Dahuangzhechong pills
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 62
Study: 19646862

Group type: EXPERIMENTAL
Intervention: Epoetin beta without antithrombotic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin beta with antithrombotic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not receiving epoetin)
Number of subjects: 0